Search

everythinglearnresearchcommunity

for

Search:↓

Low-dose naltrexone helps improve symptoms and stabilize frontal fibrosing alopecia and lichen planopilaris.

Tofacitinib helped a patient regrow hair after 40 years of total hair loss.

All four treatments for early rheumatoid arthritis had similar and mostly mild side effects.

Tofacitinib helped a teenager with severe hair loss grow hair back, but more research is needed.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

Peginterferon alpha-2a effectively treats acute hepatitis C in hemodialysed patients, despite some side effects.

Using Janus kinase inhibitors (JAKi) in COVID-19 treatment requires careful consideration due to their immunosuppressive effects.

Liarozole may be more effective than cyproterone acetate for treating advanced prostate cancer, with better PSA response and survival rates, while maintaining quality of life.

Deferasirox effectively reduces iron overload in ß-thalassemia patients but may cause some manageable side effects.

Finasteride is high-risk for cognitive disorders, while Carbidopa/Levodopa, Topiramate, and Clonazepam are moderate-risk.

Ruxolitinib may help treat hair loss and symptoms in patients with chronic graft-versus-host disease.

Imatinib mesylate can cause skin lightening, especially in Chinese patients, due to its effect on pigment production.

Photodynamic therapy improved skin issues from sorafenib when other treatments failed.

Voriconazole can cause serious side effects, especially in long-term use.

ZD1839, a cancer drug, can cause mild skin rashes that are treatable without stopping the medication.

Isotretinoin with tacrolimus may be more effective short-term for treating frontal fibrosing alopecia than finasteride with tacrolimus.

CTP-543 is generally safe for treating alopecia areata.

JAK inhibitors may become the first approved treatment for alopecia areata if they are proven safe and effective.

Kerion, a scalp fungal infection, requires lab confirmation and is treated with antifungal medication and medicated shampoo.

Ritlecitinib effectively regrows hair in severe alopecia areata and is well tolerated.

Tofacitinib is effective and safe for treating severe hair loss in a Saudi population.

Combining CAF regimen with fufangbanmao capsules improves thyroid cancer treatment outcomes and reduces side effects.

Tofacitinib effectively regrows hair in alopecia areata but may need continuous use.

Methotrexate is not proven to maintain remission in ulcerative colitis.

Anticancer drugs like methotrexate and trimetrexate could be effective and safe for treating malaria at low doses.

Some people experience severe, long-lasting side effects from fluoroquinolone antibiotics, leading to the recommendation of limited use and increased awareness of these risks.

Tofacitinib and ruxolitinib are effective and safe for treating various autoimmune skin and joint disorders.

Vemurafenib therapy can cause hair loss, but clobetasol propionate foam can help regrow hair.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.